Filing Flows › Utah Medical Products (UTMD) › Neonatal revenue
Utah Medical Products (UTMD) Neonatal revenue by quarter
Utah Medical Products' Neonatal revenue was $1.9M in Q2 2026 (second quarter 2026), +22% from Q1 2026. Over the last 5 quarters it ranged from $1.6M (Q1 2026) to $2.2M (Q3 2025).
| Quarter | Neonatal revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.9M | +22% | -9% |
| Q1 2026 | $1.6M | -28% | -21% |
| Q3 2025 | $2.2M | +4% | — |
| Q2 2025 | $2.1M | +6% | — |
| Q1 2025 | $2.0M | — | — |
Q2 2026 at a glance
Utah Medical Products, Q2 2026: revenue $8.5M (-14% year over year), operating margin 31.1%, net earnings $2.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Utah Medical Products' Neonatal revenue?
Utah Medical Products' Neonatal revenue was $1.9M in Q2 2026 (second quarter 2026), +22% from Q1 2026.
How has Utah Medical Products' Neonatal revenue changed?
Over the last 5 quarters it ranged from $1.6M (Q1 2026) to $2.2M (Q3 2025).